Beta Pharma is an emerging specialty pharmaceutical company dedicated to the discovery, development and commercialization of innovative late stage therapies targeting oncology. Our products pipeline is diverse and undergoing rapid development. Beta Pharma Inc. was founded in 1996, at Science Park of Yale, as a contract research organization (named Beta Chemicals Inc.) to provide custom synthesis service for the pharmaceutical and biotechnology R&D community. In May of 2006, our novel EGFR inhibitor, Icotinib, entered into a Phase I clinical trial in China. The SFDA approved Icotinib on June 7, 2011. The global registration of Icotinib is undergoing, with our regional partners worldwide.
View Top Employees from Beta Pharma, Inc.Website | http://www.betapharma.com |
Revenue | $16 million |
Employees | 34 (29 on RocketReach) |
Founded | 1996 |
Address | 5 Vaughn Dr, Princeton, New Jersey 08540, US |
Phone | (609) 436-4100 |
Fax | (609) 919-1516 |
Technologies |
JavaScript,
HTML,
PHP
+16 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Manufacturing General, Oncology, Manufacturing, Pharmaceuticals, Drug Discovery, Major Product: Icotinib |
Web Rank | 12 Million |
Keywords | Beta Pharmaceuticals, Icotonib Hcl China, Beta Pharma, Bpi-7711, Icotinib Fda |
Competitors | Agilux Laboratories, A Charles River Laboratories Company, Innovus Pharmaceuticals Inc, Nymox Pharmaceutical Corp, Sophiris Bio Inc., Wolfe Laboratories, Inc. |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular Beta Pharma, Inc. employee's phone or email?
The Beta Pharma, Inc. annual revenue was $16 million in 2024.
Mike Greco is the Vice President, Research and Development of Beta Pharma, Inc..
29 people are employed at Beta Pharma, Inc..
Beta Pharma, Inc. is based in Princeton, New Jersey.
The NAICS codes for Beta Pharma, Inc. are [32, 325, 3254, 32541].
The SIC codes for Beta Pharma, Inc. are [28, 283].